Literature DB >> 8380974

Purification of dihydroxyacetone phosphate acyltransferase from guinea pig liver peroxisomes.

K O Webber1, A K Hajra.   

Abstract

Dihydroxyacetone phosphate acyltransferase (EC 2.3.1.42), a peroxisomal enzyme which initiates the biosynthesis of glycerolipids (especially the ether-linked glycerolipids) in higher eukaryotes, has been purified by over 3250-fold from guinea pig liver. Initial stages of purification entailed isolation of liver peroxisomes by a combination of differential and density-gradient centrifugation. Dihydroxyacetone phosphate acyltransferase was solubilized from peroxisomal membranes with 3-[3-cholamidopropyl)dimethylammonio]-1-propane sulfonate at moderate ionic strength (0.15 M NaCl). The solubilized enzyme was further purified by a regimen of size-exclusion chromatography, cation-exchange chromatography, and hydroxylapatite chromatography. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of different fractions during the purification of the enzyme, a 69-kDa protein band copurified with the enzyme activity, indicating that the monomeric enzyme may have a M(r) of 69,000. This was verified by further purifying the enzyme by chromato-focusing, when a single 69-kDa band was observed on SDS-PAGE. The M(r) of dihydroxyacetone phosphate acyltransferase determined by gel filtration is 90 kDa. The Vmax of the purified enzyme was approximately 4 mumol acyldihydroxyacetone phosphate (acylDHAP) formed per minute per milligram protein and the Km(DHAP) is approximately 70 microM when assayed at saturating concentrations of palmitoyl-CoA. Free coenzyme A inhibits the acyltransferase reaction with an inhibition constant (Ki) of approximately 0.76 mM. To date, this is the most highly purified DHAP acyltransferase (> 3200-fold) of mammalian origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380974     DOI: 10.1006/abbi.1993.1013

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol.

Authors:  N Nagan; A K Hajra; L K Larkins; P Lazarow; P E Purdue; W B Rizzo; R A Zoeller
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 2.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

3.  Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells.

Authors:  R J Wanders; R Ofman; G J Romeijn; R B Schutgens; P A Mooijer; C Dekker; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium.

Authors:  Anne P Beigneux; Laurent Vergnes; Xin Qiao; Steven Quatela; Ryan Davis; Steven M Watkins; Rosalind A Coleman; Rosemary L Walzem; Mark Philips; Karen Reue; Stephen G Young
Journal:  J Lipid Res       Date:  2006-01-31       Impact factor: 5.922

5.  Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis.

Authors:  Masanori Honsho; Shunsuke Asaoku; Yukio Fujiki
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

6.  Leishmania dihydroxyacetonephosphate acyltransferase LmDAT is important for ether lipid biosynthesis but not for the integrity of detergent resistant membranes.

Authors:  Rachel Zufferey; Gada K Al-Ani; Kara Dunlap
Journal:  Mol Biochem Parasitol       Date:  2009-08-29       Impact factor: 1.759

7.  Human and great ape red blood cells differ in plasmalogen levels and composition.

Authors:  Ann B Moser; Steven J Steinberg; Paul A Watkins; Hugo W Moser; Krishna Ramaswamy; Kimberly D Siegmund; D Rick Lee; John J Ely; Oliver A Ryder; Joseph G Hacia
Journal:  Lipids Health Dis       Date:  2011-06-17       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.